In the fight against cancer, funding for early-stage researchers and early-stage biotechnology is critical
Leading CEO of Cure Brain Cancer Foundation, Lance Kawaguchi, is spearheading support for new innovation to beat cancer.
Kawaguchi firmly believes that there must be more support for early-stage researchers and early-stage biotechnology. He knows that solving this problem can ultimately change the way cancer is approached.
Leading experts collaborate on cancer cure mission
Ticker’s Holly Stearnes sat down with Kawaguchi, alongside Professor Webster Cavenee and Dr. Alfred Yung. Together, they spoke about the importance of funding for early-stage researchers and early-stage biotechnology.
Cavenee is the Chairperson of our Scientific Advisory Committee & Director at the Ludwig Cancer Research, San Diego.
He has fundamentally changed the way scientists think about the onset of cancer and its progression.
Yung is an integral part of Neuro-Oncology at the MD Anderson Cancer Center. He is an expert in clinical research and treatment of glioblastoma multiforme.
Yung is also a 17-year cancer survivor and was recently named to the Blue Ribbon panel of experts selected to advise the Beau Biden Cancer Moonshot.
Investing in early-stage researchers
Researchers are an integral part of the fight against all cancers. They work tirelessly to find a cure or treatment to ensure a better outcome for those who have fallen victim to the disease.
However, far too often, many early-career researchers miss out on critical funding to enhance and enable their remarkable work.
Many early-stage researchers are exposed to discrimination in the industry and frequently denied access to grants. Instead, grants are mostly given to late-career researchers.
The hierarchy in the industry means that up and coming researchers and some of the best minds in the world regularly get overlooked.
However, these minds and fresh ideas are the key to trying new innovations and potentially a cure for a disease that impacts millions of people every day.
The future depends on rising researchers and the innovation they bring.
Cure Brain Cancer Foundation is transforming the way cancer is approached and injecting much-needed awareness. Cancer is more than just a cause, it’s a movement.
Challenges for early-stage biotechnology
Biotechnology is the key to finding a cure for cancer. However, its innovative ideas don’t always make it to fruition because they face enormous setbacks within the industry.
Early-stage biotechs need funding to begin and continue to operate. The market in general is saturated and extremely hard to eventuate.
Combatting early stages of a new biotechnology company can be difficult.
However, focusing on quality science, strategic management, securing funding, staffing, and regulatory compliance can increase the chances of success.
Cancer knows no boundaries
Yung treated U.S. President Joe Biden’s oldest son, Beau Biden, before his death of brain cancer, aged 46.
Yung has been recognised by the Biden family, for his attempt to save Beau’s life.
The Biden administration launched the ‘Cancer Moonshot’ initiative in a bid to halve the rate of cancer deaths by 2047. The President made mention of Yung when launching the initiative.
Trusting in CBCF
Lead by Kawaguchi, Cure Brain Cancer Foundation, is adding urgency to the fight against cancer.
They’re putting processes in place to give funding to early-stage researchers and early-stage biotechs, who have the ability to innovate the way cancer is approached.
Both Yung and Cavenee are highly respected in cancer research and have chosen to partner with Kawaguchi in his mission to find a cure for brain cancer.
Global market forces and OCIO adoption
Do global markets and economic climate influence OCIO adaption with investors?
In a recent Institutional Investor report, the outsourced chief investment officer (OCIO) industry is on the brink of substantial growth, driven by increasing interest from asset owners, especially endowments and foundations, who are increasingly turning to OCIO services.
To delve deeper into this trend, we are privileged to introduce Jim Schienberg, Managing Partner at North Pier Search Consulting, a renowned OCIO search firm.
Netflix’s ‘Live to 100’ series: exploring longevity & financial planning
What does a philosophy about lifestyle choice have to do with money management?
Netflix has unveiled its latest docuseries, “Live to 100: Secrets of the Blue Zones,” featuring bestselling author Dan Buettner. In this captivating series, Buettner travels the world, uncovering the lifestyles and diets of centenarians in Blue Zones—regions known for their high concentration of long-lived individuals. The series sheds light on the remarkable factors contributing to their extended lifespans.
To delve into the financial implications of living longer, we sat down with Judith Lu, CEO of Blue Zone Wealth Advisors. Lu, an expert in financial planning, discusses retirement strategies, healthcare costs, and the importance of long-term financial planning in the context of extended life expectancy. “Live to 100” offers viewers not only a glimpse into the secrets of centenarians but also valuable insights into securing a financially sound future in an age of longevity. Watch the series on Netflix to discover the keys to a longer, healthier life, and explore the financial strategies that can help you make the most of it.
Changing the game in redefining startup funds
Redefining the way startup funds are managed and operated
In an exciting development for the Australian startup ecosystem, VentureCrowd has joined forces with Pitch VC and is poised to redefine the way startup funds are managed and operated, with empowering subject matter experts and highly networked individuals to launch and operate their own startup venture capital fund.
Pitch VC co-founder Campbell Walshe discusses how this partnership will help democratise the venture capital ecosystem.
First home purchases cost 60% more than renting in most cities
UPS is using AI to thwart package theft
How much money you need to earn to be “officially rich”
Crypto.com accidentally transfers $10.5m to woman instead of $100
What is happening between SHIB and Vitalik? | TICKER VIEWS
Russia has cancelled itself. But the world should beware of poking the Russian bear￼
Money5 days ago
Top 5 simple digital nomad jobs for newbies
Originals5 days ago
How will the energy market change
News2 days ago
Why regulators are targeting board execs for cyber security failures
Money5 days ago
Meta offers employee benefits following mass layoffs
News4 days ago
Millennials are suddenly ditching the Bali nomad lifestyle
News1 day ago
Tim Cook joins NYC iPhone 15 launch, draws global crowds
Money5 days ago
Dominant oil cartel’s grip on fuel prices may weaken
News4 days ago
How can AI sound more human?